The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 30, 2024
Filed:
Apr. 15, 2022
Applicants:
University of Washington, Seattle, WA (US);
Abacus Bioscience, Inc., Sammamish, WA (US);
Inventors:
Edward A. Clark, Seattle, WA (US);
Deborah L. Fuller, Seattle, WA (US);
Che-Leung Law, Seattle, WA (US);
Amanda Mak, Seattle, WA (US);
Assignee:
Abacus Bioscience, Inc., Seattle, WA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 39/29 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); C07K 16/28 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/292 (2013.01); A61K 39/001129 (2018.08); A61K 39/39 (2013.01); C07K 16/2896 (2013.01); C12N 7/00 (2013.01); C07K 2317/524 (2013.01); C07K 2317/526 (2013.01); C07K 2317/56 (2013.01); C07K 2317/622 (2013.01); C07K 2319/00 (2013.01); C12N 2730/10134 (2013.01);
Abstract
Provided herein are compositions of CD1280 binding proteins and a Hepatitis B virus core antigen (HBcAg) and/or a Hepatitis B virus E antigen (HBeAg), or antigenic fragments or mutants thereof, attached to the CD180 binding protein, and methods for using the compositions to treat or limit the development of hepatitis-B virus (HBV)-related disorders.